What the company does
MedinCell S.A., a clinical-stage and commercial biopharmaceutical licensing company, develops long acting injectables in various therapeutic areas in France. The company develops solutions based on BEPO, a long-acting injectable technology. It offers UZEDY (mdc-IRM) for the treatment of schizophrenia in adults and bipolar I disorder. It is also developing mdc-TJK, a subcutaneous injection that is in the NDA preparation stage for the treatment of schizophrenia in adults; and mdc-CWM, a sustained-release formulation of celecoxib in Phase III trials for use in the treatment of reduction of postoperative pain and inflammation in total knee arthroplasty surgery. …
What the weekly tape is saying
MEDCL closed the latest completed week at 27.42 EUR. The 4-week return is 0.1% and the 12-week return is 35.5%. Trend Signal is inactive, Market Dynamics is 0.99. Setup signature: Deep recovery attempt with a 53/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 25.06 EUR
- Vs Trend Line
- 9.4%
- Fair Value
- 16.00 EUR
- Vs Fair Value
- 71.3%
- 52W High
- 39.68 EUR
- 52W Low
- 15.00 EUR
- Drawdown
- -30.9%
- Range Position
- 50.3%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 31
- 52W Active Breadth
- 59.6%
- Sector Scope
- FR Healthcare
- Sector Rank
- 11 of 76
- Sector Percentile
- 86.7%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
FR Healthcare
- Tracked Peers
- 76
- 4W Rank
- 23 of 76
- Avg 1W
- -2.1%
- Avg 4W
- -5.9%
- Trend Breadth
- 28.9%
- Positive MD
- 48.7%
FR Biotechnology
- Tracked Peers
- 33
- 4W Rank
- 6 of 33
- Avg 1W
- -2.8%
- Avg 4W
- -11.9%
- Trend Breadth
- 27.3%
- Positive RS
- 21.2%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.99
- 4W MD Change
- 112.6%
- Relative Strength
- 10.88
- 4W RS Change
- -46.1%
- Expectation
- Positive
- Probability
- 58.22%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 415.4K
- 13W Average
- 509.3K
- 52W Average
- 581.4K
- Vs 13W
- 0.8x
- Vs 52W
- 0.7x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 4.1%
- 52W Volatility
- 8.0%
- Upside Weeks
- 29
- Downside Weeks
- 23
- Downside Breadth
- 44.2%
- Avg Gain / Loss
- 6.7% / -5.2%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- PAR
- Country
- FR
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- EUR
- Market Cap
- 1.0B
Opportunity signals
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Market Dynamics is positive on the latest completed week.
- Latest weekly return ranks in the strongest part of its sector group.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 27.42 EUR | 2.2% | 25.06 EUR | 16.00 EUR | 0.99 | 10.88 | 415.4K | Off |
| 5 Jun 2026 | 26.84 EUR | -5.0% | 25.16 EUR | 15.87 EUR | 1.08 | 11.20 | 646.0K | Off |
| 29 May 2026 | 28.26 EUR | 4.0% | 25.32 EUR | 15.75 EUR | 1.06 | 18.51 | 635.9K | Off |
| 22 May 2026 | 27.18 EUR | -0.7% | 25.66 EUR | 15.61 EUR | 0.79 | 15.93 | 524.5K | Off |
| 15 May 2026 | 27.38 EUR | 4.4% | 25.96 EUR | 15.48 EUR | 0.46 | 20.17 | 575.5K | Off |
| 8 May 2026 | 26.22 EUR | 6.2% | 26.17 EUR | 15.35 EUR | 0.08 | 13.96 | 591.1K | Off |
| 1 May 2026 | 24.68 EUR | 6.6% | 26.21 EUR | 15.22 EUR | -0.38 | 8.14 | 603.9K | Off |
| 24 Apr 2026 | 23.16 EUR | -4.5% | 26.28 EUR | 15.12 EUR | -0.65 | 1.67 | 506.3K | Off |
| 17 Apr 2026 | 24.26 EUR | 4.5% | 26.25 EUR | 15.03 EUR | -0.76 | 3.73 | 476.3K | Off |
| 10 Apr 2026 | 23.22 EUR | 0.5% | 26.15 EUR | 14.93 EUR | -0.97 | 1.94 | 361.0K | Off |
| 3 Apr 2026 | 23.10 EUR | 4.1% | 26.05 EUR | 14.84 EUR | -1.06 | 5.94 | 267.5K | Off |
| 27 Mar 2026 | 22.20 EUR | 9.7% | 25.84 EUR | 14.76 EUR | -1.18 | 6.04 | 534.8K | Off |
| 20 Mar 2026 | 20.24 EUR | -0.5% | 25.68 EUR | 14.68 EUR | -1.19 | -2.17 | 482.5K | Off |
| 13 Mar 2026 | 20.34 EUR | -4.6% | 25.60 EUR | 14.60 EUR | -1.16 | -4.22 | 546.4K | Off |